How deadly is Breast cancer?

Apa kanker payudara kuwi mbebayani banget?

Kanker payudara minangka penyakit sing serius lan bisa uga mbebayani.

Iki minangka kanker sing paling umum ing antarane wanita ing saindenging jagad lan panyebab utama kaping pindho kematian kanker ing wanita.

Miturut American Cancer Society, ing taun 20220, kira-kira 276.480 kasus anyar kanker payudara invasif didiagnosis ing wanita ing Amerika Serikat, lan udakara 42.170 wanita ing Amerika Serikat tilar donya amarga kanker payudara.

Nanging, tingkat kematian saka kanker payudara wis mudhun wiwit taun 1989, kanthi penurunan 40% ing tingkat kematian kanker payudara saka taun 1989 nganti 2017, utamane amarga perbaikan deteksi lan perawatan awal.

Resiko mati amarga kanker payudara beda-beda gumantung karo faktor kayata umur, tahap nalika didiagnosis, lan jinis kanker payudara.

Deteksi lan perawatan awal bisa nambah kemungkinan slamet kanthi signifikan.

Referensi-referensi

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011, 104 (6): 910-4.

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 2019, 69 (6): 438-451.

Icaza G, Núñez L, Bugueño H: [Epidemiological analysis of breast cancer mortality in women in Chile]. Rev Med Chil. 2017, 145 (1): 106-114.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA: Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017, 14 (9): 1137-1143.

Deaths from breast cancer--United States, 1991. MMWR Morb Mortal Wkly Rep. 1994, 43 (15): 273, 279-81.

Kuroishi T, Hirose K, Suzuki T, Tominaga S: Effectiveness of mass screening for breast cancer in Japan. Breast Cancer. 2000, 7 (1): 1-8.

Penafian: medis

Situs web iki diwenehake mung kanggo tujuan pendhidhikan lan informasi lan ora dadi menehi saran medis utawa layanan profesional.

Informasi sing diwenehake ora kudu digunakake kanggo diagnosa utawa ngobati masalah utawa penyakit kesehatan, lan wong-wong sing golek saran medis pribadi kudu takon karo dokter sing duwe lisensi.

Mangga dicathet jaringan saraf sing ngasilake wangsulan kanggo pitakonan, utamané ora akurat nalika nerangake konten numerik. Contone, jumlah wong sing didiagnosis karo penyakit tartamtu.

Tansah golek saran saka dhokter utawa panyedhiya kesehatan sing berkualitas liyane babagan kahanan medis. Aja ora nggatekake saran medis profesional utawa telat nggoleki amarga apa sing wis diwaca ing situs web iki. Yen sampeyan mikir sampeyan bisa duwe darurat medis, nelpon 911 utawa pindhah menyang kamar darurat paling cedhak langsung. Ora ana hubungan dokter-pasien sing digawe dening situs web iki utawa panggunaan. Ora BioMedLib utawa karyawan, utawa kontributor situs web iki, nggawe perwakilan, ekspres utawa tersirat, babagan informasi sing diwenehake ing kene utawa panggunaan.

Penafian: hak cipta

Undhang-undhang Hak Cipta Milenium Digital taun 1998, 17 U.S.C. § 512 ( DMCA) nyedhiyakake recourse kanggo pamilik hak cipta sing percaya yen materi sing katon ing Internet nglanggar hak-hak miturut hukum hak cipta AS.

Yen sampeyan percaya kanthi tulus manawa konten utawa materi sing kasedhiya gegayutan karo situs web utawa layanan kita nglanggar hak cipta sampeyan, sampeyan (utawa agen sampeyan) bisa ngirim kabar kanggo njaluk supaya konten utawa materi kasebut dicopot, utawa akses diblokir.

Kabar kudu dikirim kanthi nulis liwat email (deleng bagean "Kontak" kanggo alamat email).

DMCA mbutuhake kabar sampeyan babagan pelanggaran hak cipta sing diduga kalebu informasi ing ngisor iki: (1) deskripsi karya hak cipta sing dadi subyek pelanggaran sing diduga; (2) deskripsi konten sing diduga nglanggar lan informasi sing cukup kanggo ngidini kita nemokake konten kasebut; (3) informasi kontak kanggo sampeyan, kalebu alamat, nomer telpon lan alamat email; (4) pernyataan dening sampeyan yen sampeyan duwe kapercayan sing apik yen konten kanthi cara sing dikritik ora diidini dening pemilik hak cipta, utawa agen, utawa dening operasi hukum apa wae;

(5) pratelan dening sampeyan, ditandatangani kanthi paukuman sumpah palsu, manawa informasi ing pemberitahuan kasebut akurat lan sampeyan duwe wewenang kanggo ngetrapake hak cipta sing diklaim dilanggar;

lan (6) tandha tangan fisik utawa elektronik saka pemilik hak cipta utawa wong sing sah tumindak atas jenenge pemilik hak cipta.

Ora kalebu kabeh informasi ing ndhuwur bisa nyebabake wektu tundha kanggo ngolah keluhan sampeyan.

Kontak karo

Mangga ngirim kita email karo sembarang pitakonan / saran.

How deadly is breast cancer?

Breast cancer is a serious and potentially deadly disease.

It is the most common cancer among women worldwide and the second leading cause of cancer death in women.

According to the American Cancer Society, in 20220, an estimated 276,480 new cases of invasive breast cancer were diagnosed in women in the United States, and about 42,170 women in the U.S. died from breast cancer.

However, the death rate from breast cancer has been declining since 1989, with a 40% decrease in the breast cancer death rate from 1989 to 2017, largely due to improvements in early detection and treatment.

The risk of dying from breast cancer varies depending on factors such as age, stage at diagnosis, and the type of breast cancer.

Early detection and treatment can significantly improve the chances of survival.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.